4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Nerve Pain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dolle, RE; Gavériaux-Ruff, C; Kieffer, BL; Le Bourdonnec, B; Little, PJ; Nozaki, C; Reiss, D; Windh, RT | 1 |
1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Nerve Pain
Article | Year |
---|---|
δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization.
Topics: Analgesia; Analgesics, Opioid; Animals; Benzamides; Benzopyrans; Disease Models, Animal; Gene Knock-In Techniques; Humans; Inflammation; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NAV1.8 Voltage-Gated Sodium Channel; Neuralgia; Neurons; Pain Measurement; Piperazines; Receptors, Opioid, delta; Spiro Compounds | 2012 |